Effects of SCN5A mutation on intracellular calcium concentration

jie gao, Ruiming Shi, Aiqun Ma, Tingzhong Wang, Junqiang Pan, Ying Lv, Junbo Zhang, Chaofeng Sun


Objective: To construct the delQKP1507-1509 mutant of SCN5A channel, and to study effects of this mutation on intracellular calcium concentration. Methods: SCN5A delQKP1507-1509 mutation was engineered using site-directed mutagenesis. Wild-type (WT), mutant (MT) and mixed (the mixture of wild-type and mutant plasmids at a ratio of 1:1) Nav1.5 plasmids were transfected into human embryonic kidney 293 (HEK293) cells respectively. Intracellular free calcium concentration were determined by laser confocal scanning microscope (LCSM) after the cells loaded with the Ca2+ indicator dye Fluo-3/AM. Results: Gel electrophoresis and DNA direct sequencing proved a deletion of nine base pairs in the SCN5A gene at position 1507-1509. Protein expression and localization of wild-type and mutant SCN5A gene in HEK293 cells were detected under the LSCM. Fluorescence intensity in wild-type group, mutant group and co-expression group (1:1 expression of WT and MT sodium channel) mimicking the heterozygous state were 79.3683±3.051, 94.6165±8.383, 90.7463±6.421 respectively, and there was no significant difference among the three groups (P>0.05). Conclusions: SCN5A delQKP1507-1509 mutant is successfully constructed and transfected into HEK293 cells. The mutation does not affect calcium concentration and further study is required to describe the possible pathophysiological mechanisms of dilated cardiomyopathy phenotype in sodium channel overlap syndromes caused by this SCN5A delQKP1507-1509 mutation.


SCN5A Mutation; Calcium Concentration; Dilated Cardiomyopathy; Cardiac sodium channel overlap syndromes

Full Text:

PDF Citation


Sanbe, A. (2013) Dilated cardiomyopathy: a disease of the myocardium. Biological & Pharmaceutical Bulletin, 36, 18-22.

Hershberger, R.E., and Siegfried, J.D. (2011) Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. Journal of the American College of Cardiology, 57, 1641-1649.

McNally, E.M., and Puckelwartz, M.J. (2015) Genetic Variation in Cardiomyopathy and Cardiovascular Disorders. Circulation Journal, 79, 1409-1415.

Olson, T.M., Michels, V.V., Ballew, J.D., Reyna, S.P., Karst, M.L., Herron, K.J., Horton, S.C., Rodeheffer, R.J., and Anderson, J.L. (2005) Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA, 293, 447-454.

Lan, F., Lee, A.S., Liang, P., Sanchez-Freire, V., Nguyen, P.K., Wang, L., Han, L., Yen, M., Wang, Y., Sun, N., Abilez, O.J., Hu, S., Ebert, A.D., Navarrete, E.G., Simmons, C.S., Wheeler, M., Pruitt, B., Lewis, R., Yamaguchi, Y., Ashley, E.A., Bers, D.M., Robbins, R.C., Longaker, M.T., and Wu, J.C. (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell, 12, 101-113.

Shi, R., Zhang, Y., Yang, C., Huang, C., Zhou, X., Qiang, H., Grace, A.A., Huang, C.L.H., and Ma, A. (2008) The cardiac sodium channel mutation delQKP 1507-1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death. Europace, 10, 1329-1335.

Wang, Q., Li, Z., Shen, J., and Keating, M.T. (1996) Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics, 34, 9-16.

Detta, N., Frisso, G., and Salvatore, F. (2015) The multi-faceted aspects of the complex cardiac Nav1.5 protein in membrane function and pathophysiology. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1854, 1502-1509.

Baskar, S., Ackerman, M.J., Clements, D., Mayuga, K.A., and Aziz, P.F. (2014) Compound heterozygous mutations in the SCN5A-encoded Nav1.5 cardiac sodium channel resulting in atrial standstill and His-Purkinje system disease. J Pediatr, 165, 1050-1052.

Darbar, D., Kannankeril, P.J., Donahue, B.S., Kucera, G., Stubblefield, T., Haines, J.L., George, A.J., and Roden, D.M. (2008) Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation, 117, 1927-1935.

Wang, D.W., Desai, R.R., Crotti, L., Arnestad, M., Insolia, R., Pedrazzini, M., Ferrandi, C., Vege, A., Rognum, T., Schwartz, P.J., and George, A.J. (2007) Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation, 115, 368-376.

Remme, C.A., Wilde, A.A., and Bezzina, C.R. (2008) Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med, 18, 78-87.

Calloe, K., Schmitt, N., Grubb, S., Pfeiffer, R., David, J.P., Kanter, R., Cordeiro, J.M., and Antzelevitch, C. (2011) Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A. Canadian Journal of Physiology & Pharmacology, 89, 723-736.

Veltmann, C., Barajas-Martinez, H., Wolpert, C., Borggrefe, M., Schimpf, R., Pfeiffer, R., Caceres, G., Burashnikov, E., Antzelevitch, C., and Hu, D. (2016) Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect. Journal of the American Heart Association, 5.

McNair, W.P., Ku, L., Taylor, M.R., Fain, P.R., Dao, D., Wolfel, E., and Mestroni, L. (2004) SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation, 110, 2163-2167.

HESSE, M., KONDO, C., CLARK, R., SU, L., ALLEN, F., GEARYJOO, C., KUNNATHU, S., SEVERSON, D., NYGREN, A., and GILES, W. (2007) Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a. Cardiovascular Research, 75, 498-509.

Zaklyazminskaya, E., and Dzemeshkevich, S. (2016) The role of mutations in the SCN5A gene in cardiomyopathies. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863, 1799-1805.

Duffee, D.F., Shen, W.K., and Smith, H.C. (1998) Suppression of Frequent Premature Ventricular Contractions and Improvement of Left Ventricular Function in Patients With Presumed Idiopathic Dilated Cardiomyopathy. Mayo Clinic Proceedings, 73, 430-433.

Sadron Blaye-Felice, M., Hamon, D., Sacher, F., Pasquale, P., Rollin, A., Bongard, V., Duparc, A., Mondoly, P., Derval, N., Denis, A., Cardin, C., Hocini, M., Jaïs, P., Pruvot, E., Schlaepfer, J., Carrié, D., Galinier, M., Lellouche, N., Haïssaguerre, M., and Maury, P. (2016) Reversal of left ventricular dysfunction after ablation of premature ventricular contractions related parameters, paradoxes and exceptions to the rule. International Journal of Cardiology, 222, 31-36.

Moreau, A., Gosselin-Badaroudine, P., Boutjdir, M., and Chahine, M. (2015) Mutations in the Voltage Sensors of Domains I and II of Nav1.5 that are Associated with Arrhythmias and Dilated Cardiomyopathy Generate Gating Pore Currents. Frontiers in Pharmacology, 6.

Zhang, T., Yong, S.L., Drinko, J.K., Popović, Z.B., Shryock, J.C., Belardinelli, L., and Wang, Q.K. (2011) LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice. International Journal of Cardiology, 147, 239-245.

Wan, E., Abrams, J., Weinberg, R.L., Katchman, A.N., Bayne, J., Zakharov, S.I., Yang, L., Morrow, J.P., Garan, H., and Marx, S.O. (2016) Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice. Journal of Clinical Investigation, 126, 112-122.

Bezzina, C.R. (2003) Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System. Circulation Research, 92, 159-168.

Ge, J., Sun, A., Paajanen, V., Wang, S., Su, C., Yang, Z., Li, Y., Wang, S., Jia, J., Wang, K., Zou, Y., Gao, L., Wang, K., and Fan, Z. (2008) Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy. Circ Arrhythm Electrophysiol, 1, 83-92.

Nguyen, T.P., Wang, D.W., Rhodes, T.H., and George, A.J. (2008) Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circulation Research, 102, 364-371.

Mann, S.A., Castro, M.L., Ohanian, M., Guo, G., Zodgekar, P., Sheu, A., Stockhammer, K., Thompson, T., Playford, D., Subbiah, R., Kuchar, D., Aggarwal, A., Vandenberg, J.I., and Fatkin, D. (2012) R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy. Journal of the American College of Cardiology, 60, 1566-1573.

Cheng, J., Morales, A., Siegfried, J.D., Li, D., Norton, N., Song, J., Gonzalez-Quintana, J., Makielski, J.C., and Hershberger, R.E. (2010) SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. Clin Transl Sci, 3, 287-294.

Despa, S., and Bers, D.M. (2013) Na+ transport in the normal and failing heart — Remember the balance. Journal of Molecular and Cellular Cardiology, 61, 2-10.

Wagner, S., Dybkova, N., Rasenack, E.C.L., Jacobshagen, C., Fabritz, L., Kirchhof, P., Maier, S.K.G., Zhang, T., Hasenfuss, G., Brown, J.H., Bers, D.M., and Maier, L.S. (2006) Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. Journal of Clinical Investigation, 116, 3127-3138.

Keller, D. (2003) A novel mutation in SCN5A, delQKP 1507–1509, causing long QT syndrome: Role of Q1507 residue in sodium channel inactivation. Journal of Molecular and Cellular Cardiology, 35, 1513-1521.

Zhang, Y., Wang, J., Chang, S., Zhou, N., Xing, H., Wang, L., Huang, C., Ma, A., Huang, C.L.H., Lei, M., and Fraser, J.A. (2014) The SCN5A Mutation A1180V is Associated With Electrocardiographic Features of LQT3. Pediatric Cardiology, 35, 295-300.

Kamdar, F., Klaassen, K.A., Koyano-Nakagawa, N., Garry, M.G., and Garry, D.J. (2015) Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies. Journal of Cardiac Failure, 21, 761-770.

DOI: http://dx.doi.org/10.15383/jbt.2017002


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

eISSN: 2616-2172


Asia Press is a professional Science, Technology and Medicine publisher, who owns rapid publication, Peer-Reviewed, Open Access Journals. Asia Press aims to promote “knowledge sharing”. As you know, the main barrier for free “knowledge sharing” is the cost of publishing and transfer. In order to encourage scholars and scientists to the max, and devote whole power to realize the aim of “knowledge sharing” and the benefit of “all” mankind, Asia Press performs a permanent policy of no charge for publication and access, and always open its door for authors worldwide.